Scleral Lens and Prosthetic Replacement of the Ocular Surface Ecosystem Utilization in Ocular Graft-versus-Host Disease: A Survey Study

被引:10
|
作者
Bligdon, Shannon M. [1 ]
Colarusso, Bradley A. [2 ]
Ganjei, Allen Y. [3 ]
Kwok, Alan [4 ]
Luo, Zhonghui Katie [2 ]
Brocks, Daniel [4 ]
机构
[1] Ajax Eye Care, Ajax, ON, Canada
[2] Massachusetts Eye & Ear, Boston, MA USA
[3] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[4] BostonSight, 464 Hillside Ave,Unit 205, Needham, MA 02494 USA
来源
CLINICAL OPHTHALMOLOGY | 2021年 / 15卷
关键词
GVHD; oGVHD; dry eye; keratoconjunctivitis sicca; QOL; HSCT; allo-HSCT; QUALITY-OF-LIFE; DRY EYE; PROSE TREATMENT; RISK-FACTORS; MANAGEMENT; DIAGNOSIS; SYMPTOMS; THERAPY; SIGNS;
D O I
10.2147/OPTH.S337824
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the utilization of scleral lenses and prosthetic replacement of the ocular surface ecosystem devices (SL/PDs) in the management of ocular graft-versus-host disease (oGVHD). Patients and Methods: A survey of 15 questions was sent via email to 6032 subjects registered with the Blood and Marrow Transplant Information Network. The survey reviewed transplant history, graft-versus-host disease history, as well as oGVHD symptoms and onset. Additional questions surveyed treatments used for oGVHD, as well as the degree of ocular symptom control and experience with SL/PDs. A total of 306 respondents met the eligibility requirements to be part of the analyzed cohort. Results: The mean number of symptoms reported from the analyzed cohort was 4.79 +/- 2.44, median (IQR) of 5.0 (3.0 to 7.0), with the most common symptom being gritty, dry eyes (87%). The mean number of treatments utilized across the analyzed cohort was 3.21 +/- 2.55, median (IQR) of 2.5 (1.0 to 5.0), with the most common treatment being artificial tears (86%). Wearing scleral lenses resulted in a mean of 5.42 +/- 1.86, median (IQR) of 6.0 (4.0 to 7.0) symptoms improving, with improved dryness/grittiness of the eyes (94%), improved eye pain (92%) and improved quality of life (89%) being the most commonly improved symptoms. Fifty-six percent of those wearing scleral lenses wished the lenses had been recommended sooner. The most common reason patients cited for not wearing scleral lenses was that they had never heard of them (63%). Conclusion: SL/PDs help to control the symptoms of oGVHD. With their use, clinicians are able to improve the quality of life of this patient population. Despite the known benefits, SL/PDs still remain underutilized in oGVHD care. A majority of current SL/PD wearers wish that they had been recommended sooner as a treatment option. SL/PDs should be considered a component of comprehensive oGVHD management.
引用
收藏
页码:4829 / 4838
页数:10
相关论文
共 50 条
  • [31] Limbus Damage in Ocular Graft-versus-Host Disease
    Lorenzo Perez, Rebeca
    Perez-Simon, Jose A.
    Caballero-Velazquez, Teresa
    Flores, Teresa
    Carrancio, Soraya
    Herrero, Carmen
    Blanco, Belen
    Gutierrez-Cosio, Silvia
    Canete-Campos, Cristina
    Cruz Gonzalez, Fernando
    San-Miguel, Jesus F.
    Hernandez-Galilea, Emiliano
    Sanchez-Abarca, Ignacio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : 270 - 273
  • [32] Ocular Graft-Versus-Host Disease Topic Review
    Hazem M Mousa
    Christopher E Starr
    Matias Soifer
    Christian Savarain
    Victor L Perez
    Current Ophthalmology Reports, 2020, 8 : 36 - 43
  • [33] Tear Osmolarity in Ocular Graft-Versus-Host Disease
    Ilhan, Abdullah
    Yolcu, Umit
    CORNEA, 2015, 34 (04) : E12 - E12
  • [34] Recent advances in ocular graft-versus-host disease
    Cheng, Xianjing
    Huang, Ruihao
    Huang, Shiqin
    Fan, Wei
    Yuan, Rongdi
    Wang, Xiaoqi
    Zhang, Xi
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] Ocular graft-versus-host disease: patient perspective
    Nau, Cherie B.
    Harthan, Jennifer S.
    Nau, Amy
    Fogt, Jennifer Swingle
    Schornack, Muriel
    Shorter, Ellen
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [36] Tear Osmolarity in Ocular Graft-Versus-Host Disease
    Berchicci, Luigi
    Iuliano, Lorenzo
    Miserocchi, Elisabetta
    Bandello, Francesco
    Modorati, Giulio
    CORNEA, 2014, 33 (12) : 1252 - 1256
  • [37] Ocular Graft-Versus-Host Disease Topic Review
    Mousa, Hazem M.
    Starr, Christopher E.
    Soifer, Matias
    Savarain, Christian
    Perez, Victor L.
    CURRENT OPHTHALMOLOGY REPORTS, 2020, 8 (02) : 36 - 43
  • [38] Improvement in Vision and Ocular Function with Prosthetic Replacement of the Ocular Ecosystem (PROSE) Scleral Lens Therapy in Exposure Keratopathy Patients
    Chahal, Jasdeep S.
    Heur, J. Martin
    Chiu, Gloria
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [39] Ocular graft-versus-host disease [Okuläre Graft-versus-Host-Disease]
    Dietrich-Ntoukas T.
    Steven P.
    Der Ophthalmologe, 2015, 112 (12): : 1027 - 1040
  • [40] Ocular pain in ocular graft-versus-host disease patients with neurotrophic keratopathy
    Wang, Shudan
    Singh, Rohan Bir
    Yuksel, Erdem
    Musayeva, Aytan
    Sinha, Shruti
    Taketani, Yukako
    Dohlman, Thomas H.
    Dana, Reza
    OCULAR SURFACE, 2022, 26 : 142 - 147